ASCO GU24 special: Dr. Andrea Apolo shares AMBASSADOR results

In this podcast, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) interviews medical oncologist Dr. Andrea Apolo from the National Cancer Institute, USA, on the results of the AMBASSADOR study, which she presented at ASCO GU24. Dr. Apolo shares details on the rationale of the AMBASSADOR study: An open-label, randomised, phase III trial, evaluating the efficacy and safety of pembrolizumab as an adjuvant treatment in muscle-invasive and locally advanced urothelial carcinoma (MIUC). &n...